PL1697378T3 - Indole, 1h-indazole, 1,2-benzoizoksazole i 1,2-benzoizotiazole oraz ich wytwarzanie i zastosowania - Google Patents

Indole, 1h-indazole, 1,2-benzoizoksazole i 1,2-benzoizotiazole oraz ich wytwarzanie i zastosowania

Info

Publication number: PL1697378T3
Authority: PL; Poland
Prior art keywords: benzisoxazoles; benzisothiazoles; indazoles; indoles; preparation
Prior art date: 2003-12-22

Application number

PL04814981T

Other languages

English (en)

Inventor

Wenge Xie

Brian Herbert

Jianguo Ma

Truc Minh Nguyen

Richard A Schumacher

Carla-Maria Gauss

Ashok Tehim

Original Assignee

Memory Pharm Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-22

Filing date

2004-12-22

Publication date

2008-04-30

2004-12-22 Application filed by Memory Pharm Corp filed Critical Memory Pharm Corp

2008-04-30 Publication of PL1697378T3 publication Critical patent/PL1697378T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/18—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Addiction (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Virology (AREA)
Obesity (AREA)
Hematology (AREA)
Psychology (AREA)
Heart & Thoracic Surgery (AREA)
Rheumatology (AREA)
Child & Adolescent Psychology (AREA)
Tropical Medicine & Parasitology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
AIDS & HIV (AREA)
Emergency Medicine (AREA)
Molecular Biology (AREA)
Endocrinology (AREA)
Anesthesiology (AREA)
Orthopedic Medicine & Surgery (AREA)

PL04814981T 2003-12-22 2004-12-22 Indole, 1h-indazole, 1,2-benzoizoksazole i 1,2-benzoizotiazole oraz ich wytwarzanie i zastosowania PL1697378T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US53089103P	2003-12-22	2003-12-22
US60689704P	2004-09-03	2004-09-03
PCT/US2004/042852 WO2005063767A2 (en)	2003-12-22	2004-12-22	Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
EP04814981A EP1697378B1 (en)	2003-12-22	2004-12-22	Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof

Publications (1)

Publication Number	Publication Date
PL1697378T3 true PL1697378T3 (pl)	2008-04-30

Family

ID=34742980

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04814981T PL1697378T3 (pl)	2003-12-22	2004-12-22	Indole, 1h-indazole, 1,2-benzoizoksazole i 1,2-benzoizotiazole oraz ich wytwarzanie i zastosowania

Country Status (22)

Country	Link
US (4)	US7396833B2 (pl)
EP (1)	EP1697378B1 (pl)
JP (1)	JP4824578B2 (pl)
KR (1)	KR20060120694A (pl)
AU (1)	AU2004309367B2 (pl)
BR (1)	BRPI0417323A (pl)
CA (1)	CA2550689A1 (pl)
CR (1)	CR8472A (pl)
DE (1)	DE602004010299T2 (pl)
DK (1)	DK1697378T3 (pl)
EC (1)	ECSP066669A (pl)
ES (1)	ES2295973T3 (pl)
IL (1)	IL176283A0 (pl)
MA (1)	MA28228A1 (pl)
NO (1)	NO20063392L (pl)
NZ (1)	NZ548228A (pl)
PL (1)	PL1697378T3 (pl)
PT (1)	PT1697378E (pl)
RS (1)	RS20060391A (pl)
RU (1)	RU2389729C2 (pl)
SG (1)	SG149830A1 (pl)
WO (1)	WO2005063767A2 (pl)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7094572B2 (en)	2003-03-14	2006-08-22	Bristol-Myers Squibb	Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
EP1742944B1 (en) *	2004-04-22	2010-11-10	Memory Pharmaceuticals Corporation	Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof
US8143254B2 (en) *	2005-02-18	2012-03-27	Cornell Research Foundation, Inc.	Methods for modulating ion channels
US8106066B2 (en)	2005-09-23	2012-01-31	Memory Pharmaceuticals Corporation	Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
WO2007038367A1 (en) *	2005-09-23	2007-04-05	Memory Pharmaceuticals Corporation	Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
WO2007056582A1 (en) *	2005-11-09	2007-05-18	Memory Pharmaceuticals Corporation	1 h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
WO2007115966A1 (en) *	2006-04-11	2007-10-18	F. Hoffmann-La Roche Ag	Heterocyclic gaba alpha subtype selective receptor modulators
WO2008005910A2 (en) *	2006-07-06	2008-01-10	Bristol-Myers Squibb Company	Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
TW200840569A (en) *	2007-03-13	2008-10-16	Targacept Inc	Sub-type selective amides of diazabicycloalkanes
KR101568884B1 (ko)	2007-03-14	2015-11-12	랜박시 래보러터리스 리미티드	포스포디에스테라제 저해제로서 피라졸로 (３,４-ｂ) 피리딘 유도체
US8697722B2 (en) *	2007-11-02	2014-04-15	Sri International	Nicotinic acetylcholine receptor modulators
JP5425915B2 (ja)	2008-10-13	2014-02-26	エフ．ホフマン−ラロシュアーゲー	二環５−（トリフルオロメトキシ）−１ｈ−３−インダゾールカルボン酸アミドの合成におけるインダゾール中間体のジアゾニウムフリーの製造方法
JO3250B1 (ar)	2009-09-22	2018-09-16	Novartis Ag	إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7
KR20120083905A (ko)	2009-10-09	2012-07-26	자프겐 코포레이션	비만의 치료에 사용하기 위한 설폰 화합물
CN102648202A (zh) *	2009-12-07	2012-08-22	塔加西普特公司	作为神经元烟碱乙酰胆碱受体配体的3,6-二氮杂双环[3.1.1]庚烷
CN102905527B (zh) *	2010-01-11	2016-08-24	阿斯特来亚治疗有限责任公司	烟碱型乙酰胆碱受体调节剂
US20110172428A1 (en)	2010-01-12	2011-07-14	Shan-Ming Kuang	Methods for the preparation of indazole-3-carboxylic acid and n-(s)-1-azabicyclo[2.2.2]oct-3-yl-1h-indazole-3-carboxamide hydrochloride salt
US8242276B2 (en)	2010-06-30	2012-08-14	Hoffmann-La Roche Inc.	Methods for the preparation of N-(S)-1-azabicyclo[2.2.2]oct-3-yl-1H-indazole-3-carboxamide hydrochloride salt
EP2595988B1 (en)	2010-07-22	2014-12-17	Zafgen, Inc.	Tricyclic compounds and methds of making and using same
KR20140006888A (ko)	2011-01-26	2014-01-16	자프겐 인크.	테트라졸화합물, 그리고, 이를 제조하는 방법 및 이를 이용하는 방법
JP5941981B2 (ja)	2011-05-06	2016-06-29	ザフゲン，インコーポレイテッド	三環式スルホンアミド化合物ならびにその製造および使用方法
CA2835261C (en)	2011-05-06	2019-06-04	Zafgen, Inc.	Partially saturated tricyclic compounds and methods of making and using same
US9242997B2 (en)	2011-05-06	2016-01-26	Zafgen, Inc.	Tricyclic pyrazole sulphonamide compunds and methods of making and using same
MX344910B (es)	2011-12-23	2017-01-11	Basf Se	Proceso para la manufactura de ariloxiacetamidas.
MX2014008706A (es)	2012-01-18	2015-03-05	Zafgen Inc	Compuestos tricíclicos de sulfonamida y métodos para elaborarlos y usarlos.
US9440943B2 (en)	2012-01-18	2016-09-13	Zafgen, Inc.	Tricyclic sulfone compounds and methods of making and using same
US8889730B2 (en)	2012-04-10	2014-11-18	Pfizer Inc.	Indole and indazole compounds that activate AMPK
JP6088491B2 (ja) *	2012-04-10	2017-03-01	大日本住友製薬株式会社	新規１位置換インダゾール誘導体
UY34893A (es)	2012-07-10	2014-02-28	Takeda Pharmaceutical	Derivados de azaindol
EA028367B1 (ru)	2012-11-05	2017-11-30	Зафджен, Инк.	Способы лечения заболеваний печени
KR20150080614A (ko)	2012-11-05	2015-07-09	자프겐 인크.	비만의 치료 및/또는 제어에서 사용하기 위한 트리시클릭 화합물
CA2890342A1 (en)	2012-11-05	2014-05-08	Zafgen, Inc.	Tricyclic compounds and methods of making and using same
CA2905242C (en)	2013-03-15	2016-11-29	Pfizer Inc.	Indole compounds that activate ampk
WO2015106012A1 (en)	2014-01-09	2015-07-16	Takeda Pharmaceutical Company Limited	Azaindole derivatives
KR101532211B1 (ko) *	2014-04-30	2015-06-30	세종대학교산학협력단	Ampk 억제기능에 기반한 뇌졸중 치료용 약학적 조성물 및 방법
WO2016054123A1 (en)	2014-09-30	2016-04-07	Lightner Derek	Methods of producing heteropolycycles via bis-epoxidation
DE102015012050A1 (de) *	2015-09-15	2017-03-16	Merck Patent Gmbh	Verbindungen als ASIC-Inhibitoren und deren Verwendungen
CN111892599B (zh) *	2020-08-14	2023-01-13	黄芳	一种2,5-二氮杂双环[2.2.2]辛烷-2-羧酸叔丁酯的合成方法
WO2022125377A1 (en) *	2020-12-08	2022-06-16	Disarm Therapeutics, Inc.	Benzopyrazole inhibitors of sarm1

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL59004A0 (en)	1978-12-30	1980-03-31	Beecham Group Ltd	Substituted benzamides their preparation and pharmaceutical compositions containing them
FI74707C (fi)	1982-06-29	1988-03-10	Sandoz Ag	Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
JPS5936675A (ja) *	1982-07-13	1984-02-28	サンド・アクチエンゲゼルシヤフト	二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド
FR2548666A1 (fr)	1983-07-08	1985-01-11	Delalande Sa	Nouveaux derives du nor-tropane et du granatane, leur procede de preparation et leur application en therapeutique
DE3429830A1 (de)	1983-08-26	1985-03-07	Sandoz-Patent-GmbH, 7850 Lörrach	Automatische carbonsaeure- und sulfonsaeureester oder -amide
US4605652A (en) *	1985-02-04	1986-08-12	A. H. Robins Company, Inc.	Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
GB8623142D0 (en)	1986-09-26	1986-10-29	Beecham Group Plc	Compounds
US4937247A (en) *	1985-04-27	1990-06-26	Beecham Group P.L.C.	1-acyl indazoles
EP0200444B1 (en) *	1985-04-27	1992-11-11	Beecham Group Plc	Azabicyclononyl-indazole-carboxamide having 5-ht antagonist activity
US5204356A (en) *	1985-07-24	1993-04-20	Glaxo Group Limited	Treatment of anxiety
GB8518658D0 (en) *	1985-07-24	1985-08-29	Glaxo Group Ltd	Medicaments
GB8520616D0 (en)	1985-08-16	1985-09-25	Beecham Group Plc	Compounds
IN166416B (pl) *	1985-09-18	1990-05-05	Pfizer
US4910193A (en) *	1985-12-16	1990-03-20	Sandoz Ltd.	Treatment of gastrointestinal disorders
NL8701682A (nl) *	1986-07-30	1988-02-16	Sandoz Ag	Werkwijze voor het therapeutisch toepassen van serotonine antagonisten, aktieve verbindingen en farmaceutische preparaten die deze verbindingen bevatten.
GB8701022D0 (en) *	1987-01-19	1987-02-18	Beecham Group Plc	Treatment
US5098909A (en) *	1987-11-14	1992-03-24	Beecham Group, P.L.C.	5-ht3 receptor antagonists for treatment of cough and bronchoconstriction
US4950759A (en) *	1988-07-07	1990-08-21	Duphar International Research B.V.	Substituted 1,7-annelated 1H-indazoles
US4895943A (en) *	1988-10-25	1990-01-23	Pfizer Inc.	Preparation of 1,4-diazabicyclo(3.2.2)nonane
EP0377238A1 (en)	1988-12-22	1990-07-11	Duphar International Research B.V	New annelated indolo (3,2-c)-lactams
US5223625A (en) *	1988-12-22	1993-06-29	Duphar International Research B.V.	Annelated indolo [3,2,-C]lactams
WO1990014347A1 (fr)	1989-05-24	1990-11-29	Nippon Shinyaku Co., Ltd.	Derives d'indole et medicament
US5446050A (en) *	1989-11-17	1995-08-29	Pfizer Inc.	Azabicyclo amides and esters as 5-HT3 receptor antagonists
GB8928837D0 (en)	1989-12-21	1990-02-28	Beecham Group Plc	Pharmaceuticals
US5098889A (en) *	1990-09-17	1992-03-24	E. R. Squibb & Sons, Inc.	Method for preventing or inhibiting loss of cognitive function employing a combination of an ace inhibitor and a drug that acts at serotonin receptors
US5192770A (en) *	1990-12-07	1993-03-09	Syntex (U.S.A.) Inc.	Serotonergic alpha-oxoacetamides
HU211081B (en) *	1990-12-18	1995-10-30	Sandoz Ag	Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same
EP0566609A1 (en)	1991-01-09	1993-10-27	Smithkline Beecham Plc	Azabicydic and azatricydic derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
JP2659107B2 (ja) *	1991-03-28	1997-09-30	エーザイ株式会社	複素環式―環式アミン誘導体
GB9121835D0 (en)	1991-10-15	1991-11-27	Smithkline Beecham Plc	Pharmaceuticals
US5273972A (en) *	1992-03-26	1993-12-28	A. H. Robins Company, Incorporated	[(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates
US5679673A (en) *	1992-09-24	1997-10-21	The United States Of America, Represented By The Department Of Health And Human Services	Aralkyl bridged diazabicycloalkane derivatives for CNS disorders
IT1256623B (it) *	1992-12-04	1995-12-12	Federico Arcamone	Antagonisti delle tachichinine, procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche
GB9406857D0 (en) *	1994-04-07	1994-06-01	Sandoz Ltd	Improvements in or relating to organic compounds
SE9600683D0 (sv)	1996-02-23	1996-02-23	Astra Ab	Azabicyclic esters of carbamic acids useful in therapy
US5952363A (en) *	1997-03-04	1999-09-14	Novo Nordisk A/S	Pyrrolidine compounds useful in the treatment of diabetes
US6624173B1 (en) *	1997-06-30	2003-09-23	Targacept, Inc.	Pharmaceutical compositions for treating and/or preventing CNS disorders
US6277870B1 (en)	1998-05-04	2001-08-21	Astra Ab	Use
US6953855B2 (en) *	1998-12-11	2005-10-11	Targacept, Inc.	3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
US7265115B2 (en) *	1999-01-29	2007-09-04	Abbott Laboratories	Diazabicyclic CNS active agents
IL144340A0 (en) *	1999-01-29	2002-05-23	Abbott Lab	Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
FR2788982B1 (fr)	1999-02-02	2002-08-02	Synthelabo	Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
FR2791678B1 (fr)	1999-03-30	2001-05-04	Synthelabo	Derives de 1,4-diazabicyclo [3.2.2] nonane-4-carboxylates et -carboxamides, leur preparation et leur application en therapeutique
WO2001004922A1 (en)	1999-07-12	2001-01-18	Mitsubishi Denki Kabushiki Kaisha	Electromagnetic contactor
SE9903760D0 (sv)	1999-10-18	1999-10-18	Astra Ab	New compounds
WO2001058869A2 (en)	2000-02-11	2001-08-16	Bristol-Myers Squibb Company	Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
GB0010955D0 (en) *	2000-05-05	2000-06-28	Novartis Ag	Organic compounds
JP2003534344A (ja)	2000-05-25	2003-11-18	ターガセプト，インコーポレイテッド	ニコチン性コリン受容体リガンドとしてのヘテロアリールジアザビシクロアルカン
FR2809732B1 (fr)	2000-05-31	2002-07-19	Sanofi Synthelabo	DERIVES DE 4(-2-PHENYLTHIAZOL-5-yl)-1,4-DIAZABICYCLO-[3.2.2] NONANE, LEUR PREPARATION ET LEUR APPLICATION ENTHERAPEUTIQUE
JP4616971B2 (ja)	2000-07-18	2011-01-19	田辺三菱製薬株式会社	１−アザビシクロアルカン化合物およびその医薬用途
US6492385B2 (en) *	2000-08-18	2002-12-10	Pharmacia & Upjohn Company	Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6599916B2 (en) *	2000-08-21	2003-07-29	Pharmacia & Upjohn Company	Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6500840B2 (en) *	2000-08-21	2002-12-31	Pharmacia & Upjohn Company	Quinuclidine-substituted heteroaryl moieties for treatment of disease
AU2002211176A1 (en)	2000-11-01	2002-05-15	Respiratorius Ab	Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3
US20020086871A1 (en) *	2000-12-29	2002-07-04	O'neill Brian Thomas	Pharmaceutical composition for the treatment of CNS and other disorders
ATE348829T1 (de) *	2001-02-06	2007-01-15	Pfizer Prod Inc	Pharmazeutische zusammensetzungen zur behandlung von störungen des zns oder anderen erkrankungen
PE20021019A1 (es)	2001-04-19	2002-11-13	Upjohn Co	Grupos azabiciclicos sustituidos
WO2002096911A1 (en) *	2001-06-01	2002-12-05	Neurosearch A/S	Novel heteroaryl-diazabicyclo-alkanes as cns-modulators
EP1403255A4 (en)	2001-06-12	2005-04-06	Sumitomo Pharma	RHO KINASE INHIBITORS
AR036040A1 (es)	2001-06-12	2004-08-04	Upjohn Co	Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen
AR036041A1 (es)	2001-06-12	2004-08-04	Upjohn Co	Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
US20030105089A1 (en)	2001-09-12	2003-06-05	Wishka Donn G.	Substituted 7-aza[2.2.1]bicycloheptanes for the treatment of disease
AP1635A (en)	2001-10-02	2006-07-14	Upjohn Co	Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease.
EP1438308A1 (en)	2001-10-26	2004-07-21	PHARMACIA & UPJOHN COMPANY	N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
US6849620B2 (en) *	2001-10-26	2005-02-01	Pfizer Inc	N-(azabicyclo moieties)-substituted hetero-bicyclic aromatic compounds for the treatment of disease
MXPA04004373A (es)	2001-11-09	2004-08-11	Upjohn Co	Compuestos heterociclicos condensados con fenilo azabiciclo para el tratamiento de enfermedades.
DE10156719A1 (de) *	2001-11-19	2003-05-28	Bayer Ag	Heteroarylcarbonsäureamide
DE10162375A1 (de)	2001-12-19	2003-07-10	Bayer Ag	Bicyclische N-Aryl-amide
DE10305922A1 (de)	2002-06-10	2004-03-04	Bayer Ag	2-Heteroarylcarbonsäureamide
JP3985139B2 (ja)	2002-02-06	2007-10-03	日本ゼオン株式会社	変性重合体およびコーティング材
EP1476448A2 (en)	2002-02-19	2004-11-17	PHARMACIA & UPJOHN COMPANY	Azabicyclic compounds for the treatment of disease
AU2003214936A1 (en) *	2002-02-20	2003-09-09	Pharmacia And Upjohn Company	Azabicyclic compounds with alfa7 nicotinic acetylcholine receptor activity
DE10211415A1 (de)	2002-03-15	2003-09-25	Bayer Ag	Bicyclische N-Biarylamide
ES2197001B1 (es)	2002-03-26	2004-11-16	Laboratorios Vita, S.A.	Procedimiento de obtencion de un compuesto farmaceuticamente activo.
US7378526B2 (en)	2002-05-07	2008-05-27	Neurosearch A/S	Azacyclic ethynyl derivatives
CA2482639A1 (en)	2002-05-30	2003-12-11	Neurosearch A/S	3-substituted quinuclidines and their use
CN1675204A (zh)	2002-06-10	2005-09-28	拜耳医药保健股份公司	2－杂芳基甲酰胺
GB0218625D0 (en)	2002-08-10	2002-09-18	Astex Technology Ltd	Pharmaceutical compounds
US20060135516A1 (en)	2002-08-10	2006-06-22	Astex Technology, Ltd.	3-(Carbonyl) 1h-indazole compounds as cyclin dependent kinases (cdk) inhibitors
SE0202430D0 (sv)	2002-08-14	2002-08-14	Astrazeneca Ab	New Compounds
SE0202465D0 (sv)	2002-08-14	2002-08-14	Astrazeneca Ab	New compounds
US7456171B2 (en) *	2002-10-08	2008-11-25	Sanofi-Aventis	1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof
FR2845388B1 (fr)	2002-10-08	2004-11-12	Sanofi Synthelabo	Derives de 1,4-diazabicyclo[3.2.2]nonanecarboxamides, leur preparation et leur application en therapeutique
US6945618B2 (en)	2003-06-02	2005-09-20	Accuride International Inc.	Drawer slide adjustment mechanism
TW200529860A (en) *	2003-12-22	2005-09-16	Astrazeneca Ab	Nicotinic acetylcholine receptor ligands
JP2005230084A (ja)	2004-02-17	2005-09-02	Olympus Corp	バルーン取付け治具
EP1742944B1 (en) *	2004-04-22	2010-11-10	Memory Pharmaceuticals Corporation	Indoles, 1h-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof

2004
- 2004-12-22 EP EP04814981A patent/EP1697378B1/en not_active Expired - Lifetime
- 2004-12-22 RS YUP-2006/0391A patent/RS20060391A/sr unknown
- 2004-12-22 PL PL04814981T patent/PL1697378T3/pl unknown
- 2004-12-22 WO PCT/US2004/042852 patent/WO2005063767A2/en not_active Ceased
- 2004-12-22 RU RU2006126540/04A patent/RU2389729C2/ru not_active IP Right Cessation
- 2004-12-22 US US11/018,429 patent/US7396833B2/en not_active Expired - Fee Related
- 2004-12-22 PT PT04814981T patent/PT1697378E/pt unknown
- 2004-12-22 SG SG200900253-6A patent/SG149830A1/en unknown
- 2004-12-22 AU AU2004309367A patent/AU2004309367B2/en not_active Ceased
- 2004-12-22 DE DE602004010299T patent/DE602004010299T2/de not_active Expired - Lifetime
- 2004-12-22 KR KR1020067012319A patent/KR20060120694A/ko not_active Ceased
- 2004-12-22 BR BRPI0417323-6A patent/BRPI0417323A/pt not_active IP Right Cessation
- 2004-12-22 NZ NZ548228A patent/NZ548228A/en not_active IP Right Cessation
- 2004-12-22 ES ES04814981T patent/ES2295973T3/es not_active Expired - Lifetime
- 2004-12-22 CA CA002550689A patent/CA2550689A1/en not_active Abandoned
- 2004-12-22 JP JP2006545564A patent/JP4824578B2/ja not_active Expired - Fee Related
- 2004-12-22 DK DK04814981T patent/DK1697378T3/da active
2006
- 2006-06-13 IL IL176283A patent/IL176283A0/en unknown
- 2006-06-14 MA MA29103A patent/MA28228A1/fr unknown
- 2006-06-21 CR CR8472A patent/CR8472A/es not_active Application Discontinuation
- 2006-06-22 EC EC2006006669A patent/ECSP066669A/es unknown
- 2006-07-21 NO NO20063392A patent/NO20063392L/no not_active Application Discontinuation
2008
- 2008-05-29 US US12/128,839 patent/US7790722B2/en not_active Expired - Fee Related
2010
- 2010-08-17 US US12/857,617 patent/US7964600B2/en not_active Expired - Fee Related
2011
- 2011-06-17 US US13/162,786 patent/US8158629B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE602004010299T2 (de)	2008-09-18
US7396833B2 (en)	2008-07-08
AU2004309367B2 (en)	2010-04-01
RU2389729C2 (ru)	2010-05-20
PT1697378E (pt)	2008-02-28
US20110028483A1 (en)	2011-02-03
MA28228A1 (fr)	2006-10-02
RS20060391A (sr)	2008-11-28
IL176283A0 (en)	2006-10-05
EP1697378B1 (en)	2007-11-21
JP2007515424A (ja)	2007-06-14
NO20063392L (no)	2006-09-21
CR8472A (es)	2007-09-07
EP1697378A2 (en)	2006-09-06
WO2005063767A2 (en)	2005-07-14
DK1697378T3 (da)	2008-03-17
CA2550689A1 (en)	2005-07-14
WO2005063767A3 (en)	2005-08-25
KR20060120694A (ko)	2006-11-27
NZ548228A (en)	2009-04-30
ES2295973T3 (es)	2008-04-16
JP4824578B2 (ja)	2011-11-30
AU2004309367A1 (en)	2005-07-14
US20050176754A1 (en)	2005-08-11
SG149830A1 (en)	2009-02-27
US20110312989A1 (en)	2011-12-22
RU2006126540A (ru)	2008-01-27
US7790722B2 (en)	2010-09-07
ECSP066669A (es)	2006-10-25
BRPI0417323A (pt)	2007-03-27
US7964600B2 (en)	2011-06-21
US20090088437A1 (en)	2009-04-02
US8158629B2 (en)	2012-04-17
DE602004010299D1 (de)	2008-01-03

Publication	Publication Date	Title
IL176283A0 (en)	2006-10-05	Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
EP1617807A4 (en)	2007-02-21	SUBSTITUTED 1,4-DIAZEPINE AND ITS USES
IL176005A0 (en)	2006-10-05	2,6-bisheteroaryl-4-aminopyrimidine derivatives and pharmaceutical compositions containing the same
PL375764A1 (pl)	2005-12-12	Indazole, benzotiazole i benzoizotiazole, sposób ich wytwarzania oraz ich zastosowanie
GB0307891D0 (en)	2003-05-14	Chemical compounds,compositions and uses
IL173299A (en)	2015-05-31	2,4-Pyrimidindiamine derivatives, preparations containing them and their use
GB0323845D0 (en)	2003-11-12	Chemical compounds,compositions and uses
SI1555267T1 (sl)	2013-05-31	2,3-DIHIDRO-6-NITROIMIDAZO(2,1-b)OKSAZOLI
EP1646382A4 (en)	2010-07-21	COMPOUNDS, COMPOSITIONS AND METHODS
EP1692112A4 (en)	2008-09-24	COMPOUNDS, COMPOSITIONS, AND METHODS
EP1716219A4 (en)	2008-05-07	WATER-SOLUBLE POLYAMINOAMIDE WITH 1,3-DIIMINENE AS SUN PROTECTION AGENT
HUP0500871A3 (en)	2006-11-28	5-aryltetrazole compounds, compositions thereof and their use
EP1594849A4 (en)	2007-07-04	COMPOUNDS, COMPOSITIONS, AND METHODS
PL394604A1 (pl)	2011-07-18	Pochodna winyloazacykloalkanowa, jej zastosowanie oraz kompozycja farmaceutyczna
IL174479A (en)	2015-08-31	The derivatives of myastrin, pharmaceutical preparations containing them and their uses
IL166821A0 (en)	2006-01-15	Novel 1,4-diazabicycloalkane derivatives their preparation and use
HUP0401092A3 (en)	2005-10-28	5-halogen-6-phenyl-7-fluoralkylamino-triazolopyrimidines as fungicides, preparation and use thereof
IL181216A (en)	2013-07-31	5, 3-SICO-4-NORKOLSTAN DERIVATIVES AND PHARMACEUTICAL COMPONENTS CONTAINING @ THEM
EG23929A (en)	2008-01-14	Isoxazolines derivatives and their use as antidepressants
EP1675834A4 (en)	2008-08-27	COMPOUNDS, COMPOSITIONS AND METHODS
EP1680420A4 (en)	2008-09-24	COMPOUNDS, COMPOSITIONS AND METHODS
PL375627A1 (pl)	2005-12-12	Pochodne 2-pirolidyn-2-ylo[1,3,4]-oksadiazolu i ich zastosowanie jako środków przeciwdepresyjnych
IL156263A0 (en)	2004-01-04	Livin-derived peptides, compositions and uses thereof
EP1620092A4 (en)	2008-04-16	COMPOUNDS, COMPOSITIONS AND METHODS
ZA200307846B (en)	2004-07-06	Latex and its preparation.